Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ITCI | RGC | JAZZ | ||
| Company | Intra-Cellular Ther | Regencell Bioscience Holdings Ltd | Jazz Pharma Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 131.90 | 30.38 | 198.96 | ||
| High | 131.98 | 30.50 | 200.00 | ||
| Low | 131.63 | 29.42 | 197.49 | ||
| Latest | 131.87 | 29.99 | 198.68 | ||
| Change | -0.05 | +0.18 | -0.65 | ||
| % Change | -0.04% | +0.60% | -0.33% | ||
| Volume | 16,062,900 | 24,425 | 376,798 | ||
| 20-Day Average Volume | 2,474,570 | 167,836 | 839,846 | ||
| Previous Close | 131.92 | 29.81 | 199.33 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 131.51 | 27.95 | 189.88 | ||
| 20-Day Raw Stochastic | 86.25% | 39.90% | 80.38% | ||
| 20-Day Relative Strength | 82.75 | 53.61 | 61.70 | ||
| Weighted Alpha | +83.21 | +67.88 | +86.99 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 40% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 03/25/25 | +5.79% since 04/09/26 | -0.16% since 04/09/26 | ||
| Low | 131.63 on 04/01/25 | 28.41 on 04/10/26 | 192.32 on 04/10/26 | ||
| High | 131.98 on 04/01/25 | 33.50 on 04/14/26 | 202.57 on 04/15/26 | ||
| 1-Month | |||||
| %Chg | +2.86% since 02/28/25 | +31.39% since 03/16/26 | +8.69% since 03/16/26 | ||
| Low | 131.18 on 03/05/25 | 22.35 on 03/17/26 | 178.32 on 03/18/26 | ||
| High | 131.98 on 04/01/25 | 40.00 on 04/01/26 | 202.57 on 04/15/26 | ||
| 3-Month | |||||
| %Chg | +57.89% since 12/31/24 | +8.64% since 01/16/26 | +16.78% since 01/16/26 | ||
| Low | 80.82 on 01/07/25 | 20.00 on 03/09/26 | 161.38 on 02/11/26 | ||
| High | 131.98 on 04/01/25 | 40.00 on 04/01/26 | 202.57 on 04/15/26 | ||
| 6-Month | |||||
| %Chg | +81.51% since 10/01/24 | +66.02% since 10/16/25 | +47.36% since 10/16/25 | ||
| Low | 70.90 on 10/07/24 | 10.33 on 11/25/25 | 128.80 on 11/07/25 | ||
| High | 131.98 on 04/01/25 | 69.00 on 01/08/26 | 202.57 on 04/15/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 14,047,056 | 14,740,718 | 12,270,755 | ||
| Shares Outstanding, K | 106,522 | 494,489 | 61,560 | ||
| Annual Sales | 680,850,000 | 0 | 4,267,590,000 | ||
| Annual Net Income | -74,680,000 | -3,580,000 | -356,150,000 | ||
| Last Quarter Sales | 199,220,000 | N/A | 1,197,930,000 | ||
| Last Quarter Net Income | -16,890,000 | N/A | 203,450,000 | ||
| 60-Month Beta | 0.46 | 2.26 | 0.23 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 02/21/25 | N/A | 6.64 on 02/24/26 | ||
| Latest Earnings Date | 05/06/25 | 01/30/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | 02/15/18 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 46.98 | ||